Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ -48.31M | $ -123.57M | 0% |
| 3/31/2025 | $ -19.18M | $ -62.52M | 0% |
| 12/31/2024 | $ 8.51M | $ -76.42M | -898.34% |
| 9/30/2024 | $ 34.61M | $ -87.48M | -252.73% |
| 6/30/2024 | $ 63.49M | $ -89.91M | -141.62% |
| 3/31/2024 | $ 7.48M | $ -146.34M | -1956.09% |
| 12/31/2023 | $ 40.81M | $ -143.1M | -350.65% |
| 9/30/2023 | $ 77.17M | $ -139.77M | -181.12% |
| 6/30/2023 | $ 106.83M | $ -141.59M | -132.53% |
| 3/31/2023 | $ 133.42M | $ -158.02M | -118.44% |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) ROIC stands at -94.5%.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average ROIC has been -315.92%.
- The median ROIC for KARYOPHARM THERAPEUTICS INC during this period was -152.28%
- KARYOPHARM THERAPEUTICS INC reached its highest ROIC over the past 5 years at -94.5%.
- The lowest ROIC recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe -1956.09%
KARYOPHARM THERAPEUTICS INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for KARYOPHARM THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -201.5M ] / Inv. Capital [ $ 213.22M ]
(=) ROIC [ -94.5% ] KPTI - Return on Invested Capital, Last 5 years
-1956.09%
Minimum
Mar 31, 2024
-94.5%
Maximum
Sep 30, 2020
-315.92%
Average
-152.28%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.69% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.69% |
| median | 3.38% |
| std | 15.18% |